CDC Pink Book Webinars 2020

Beginning July 1, the CDC is offering weekly one-hour videos that provide an overview of vaccination principles, general best practices, immunization strategies, and specific information about vaccine-preventable diseases and the vaccines that prevent them. Each video will also include recent updates from the Advisory on Immunization Practices meetings.

The intended audience is all immunization providers, and continuing education will be available for each video. Due to COVID-19, the videos will be on demand and prerecorded rather than live. No registration is required, and videos will be released on Wednesdays through October 14. Videos can be accessed here.

The 2020 release schedule is below:

DateTopic
July 1Principles of Vaccination
July 8General Best Practice Guidelines, Part 1
July 15General Best Practice Guidelines, Part 2, and Vaccine Safety
July 22Immunization Strategies
July 29Vaccine Storage and Handling and Vaccine Administration
August 5DTaP/Tdap
August 12Rotavirus and Hepatitis A
August 19Meningococcal Vaccine
August 26Mealses, Mumps, Rubella

WellConnect Automated Patient Reminders

With the current challenges of getting patients back into the office, it’s a great time to look into resources to help connect with families. Sanofi Pasteur offers a helpful tool to deliver important reminders to your patients. WellConnect is available at VaccineShoppe.com and has both text and voice messaging capabilities.  Sanofi Pasteur created a helpful information sheet.

WellConnect can be used for:

  • Flu and other immunization reminders
  • Patient wellness checks and physicals
  • Appointment reminders
  • Back-to-School health reminders
  • Medical screenings and health clinics

In addition, WellConnect has a number of helpful features such as survey capabilities and analytics. You can create an account at VaccineShoppe.com as well as access free resources and training materials. For more information, reach out to your Vaccine Specialist.

Webinar: Hepatitis B Overview and Innovations in Immunization

Dynavax is hosting a webinar on Hepatitis B presented by: John Youhanna, PharmD, RPh, Regional Medical Director, Dynavax Technologies.

Now more than ever, it is important to prioritize the protection of healthcare workers who are at risk from infectious diseases, particularly hepatitis B, a potentially deadly virus that is spread through contact with infected blood and bodily fluids and can live on surfaces for at least seven days.1,2,3

Please join us to discuss why Hepatitis B is a current threat to our healthcare community and learn more about innovations in protection through vaccination.

This educational presentation will include a live Q & A session.

Click below to register!

June 18th

1pm – 2pm EST

June 23rd

2pm – 3pm EST

June 25th

12pm – 1pm EST

1 Centers for Disease Control and Prevention. Hepatitis B. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015:149-174. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hepb.pdf. Accessed October16, 2017.

2. Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol.2015;7(24):2503-2509. doi:10.4254/wjh.v7.i24.2503

3. Than TT, Jo E, Todt D, et al. High environmental stability of hepatitis B virus and inactivation requirements for chemical biocides. J Infect Dis. 2018 Oct 24. doi: 10.1093/infdis/jiy620. [Epub ahead of print].

National Infant Immunization Week

Today kicks off National Infant Immunization Week (NIIW), a yearly observance of the importance of vaccinating children two years and younger. NIIW runs April 25-May 2, 2020 as part of World Immunization Week, a World Health Organization Initiative. NIIW highlights major achievements in the control of vaccine-preventable diseases and brings attention to the challenges that remain. An overview of NIIW can be found here.

The CDC’s NIIW hub provides a wide variety of resources for healthcare professionals to use during this week. The Digital Media Toolkit has social media messages, content, and materials for your practice to share. These include graphics pre-sized for Facebook, Instagram, and Twitter. In addition, the Toolkit has flyers, posters, infographics, and videos.

If you’ve been waiting for the right time to focus on building a culture of immunization in your practice, NIIW might be it! The CDC has a wealth of resources to help including a presentation on 10 Ways to Create a Culture of Immunization Within Our Pediatric Practice. This slide deck can be customized for your practice, and it comes complete with notes and guidance.  

Sanofi Pasteur also has a helpful resources for creating a culture of immunization called Developing an Immunization Culture in Your Office. This handout breaks down broad ideas concerning immunization culture into succinct, actionable bullet points.

NIIW is also a good time to review educational resources on immunization. The CDC provides resources for healthcare providers and for parents. The resources for providers equip healthcare professionals with the answers to many vaccine-related questions from parents. These include webinars, articles, printable resources, and social media content. In addition, providers can use the hub Provider Resources for Vaccine Conversations with Parents. These materials were created by the CDC, AAP, and AAFP.

We hope that your practice will take some time this week to reflect on the importance of infant immunizations and the profound impact these vaccines have had in reducing vaccine preventable diseases. Happy National Infant Immunization Week!  

New Discount Opportunity for CPP Members

One of the most important elements of vaccine storage is utilizing an accurate temperature monitoring device that has been properly maintained.

According to the CDC Vaccine Storage & Handling Toolkit:

Calibration testing should be done every one to two years or according to the manufacturer’s suggested timeline. TMDs can experience a “drift” over time, affecting their accuracy. This testing ensures the accuracy of the device continues to conform to nationally-accepted standards.

If you need to replace the temperature monitoring device at your practice or if the cost of calibration testing outweighs the cost of purchasing a new device, CPP members can access a discount on LogTag Vaccine Temperature Monitoring Kits.  Simply contact the CPP office at mailto:cpp@nationwidechildrens.org for more information.

Merck’s Pediatric Recombivax HB Available March 9, 2020

As announced at the ACIP meeting last week, supply of the pediatric formulation of Merck’s Recombivax HB will be returning to the private sector.  The following vaccine presentations will be available for purchase beginning March 9, 2020:   

CPP members can purchase Merck vaccines directly from Merck or through a Merck Vaccines Prime Distributor to receive the CPP member discounts.        

At this time, the adult formulations of Recombivax HB are still unavailable.  You can keep up on supply updates by visiting the Merck Supply Status website.  Remember, CPP members can access a discount on Dynavax’s Heplisav-B, a 2-dose hepatitis B vaccine series for adult patients.  To participate in this discount opportunity, contact the CPP office to request an opt-in form.  Once your practice is linked to the CPP member discount, doses can be purchased through an authorized distributor of Heplisav-B.   

If you have any questions or would like additional information, please contact the CPP Office at 614-722-2145 or your Merck representative.

Shared Clinical Decision-Making: Understanding the Recommendations from the CDC

The immunization schedules for 2020 recently published by the Center for Disease Control (CDC) four recommendations for vaccination based on shared clinical decision-making. These vaccines are:

  • Meningococcal B (MenB) vaccination for adolescents and young adults aged 16–23 years
  • Human papillomavirus (HPV) vaccination for adults aged 27–45 years
  • Pneumococcal conjugate vaccination (PCV13) for adults aged 65 years and older who do not have an immunocompromising condition, cerebrospinal fluid leak, or cochlear implant
  • Hepatitis B (HepB) vaccination for adults age 60 years and older with diabetes mellitus

But what is a shared clinical decision-making recommendation? According to the CDC, an immunization is given this designation when it is not indicated for all members of a population. The vaccination may benefit some members of the age or risk group, but broad vaccination of people in that group is unlikely to have population-level impacts. For shared clinical decision-making immunizations, patients and providers should discuss the potential benefits of vaccination and come to a personalized decision together.

Over the next month, we will examine the individual immunizations that the ACIP recommends for shared clinical decision-making.

HPV

The HPV vaccination is routinely recommended for ages 11 or 12 with catch-up recommendations for those not vaccinated on time.

In June 2019, the ACIP recommended shared clinical decision-making for HPV vaccination of adults aged 27–45 years. According to the ACIP Shared Clinical Decision-Making Recommendations, HPV acquisition generally occurs soon after first sexual activity. Vaccine effectiveness is lower in older age groups because of prior infections and lower risk of exposure (for example, among persons who are in a long-term, mutually monogamous sexual partnership). The ACIP recommended shared clinical decision-making rather than catch-up vaccination because most adults in this age group would have no or minimal benefits from vaccination. However, some individuals who are not already immune to HPV through vaccination or natural infection (e.g., a previously unvaccinated person who has never had sex) and who might be at risk for acquiring a new HPV infection in the future (e.g., plans to have sex with a new partner in the future) might benefit from vaccination.

A detailed explanation of the ACIP’s recommendation and considerations for shared clinical decision making regarding HPV vaccination of adults aged 27 through 45 years can be found on the HPV Updated Recommendations webpage.

HPV Best Practices and Toolkit

Both the National Foundation for Infectious Diseases and the American Academy of Pediatrics have a wealth of resources to aid in improving HPV vaccination rates. These include clinical resources, printable documents for patient education, videos, and webinars. Below is an overview of the resources provided by each organization.

The AAP’s HPV Champion Toolkit has resources to help you:

  • Educate other healthcare professionals
  • Discuss HPV vaccination with parents
  • Make necessary changes in your practice to improve HPV vaccination rates.

The site includes a collection of printable resources for clinicians, caregivers, and preteens/teens. Materials for caregivers are available in multiple languages. It also contains a plan for implementing a change in your office related to the HPV vaccine. The plan uses the Plan, DO, Study, Act (PDSA) improvement cycle, and provides resources for introducing standing orders, giving strong recommendations, using reminder recall systems, and more. In addition, there are teaching tools including a communication simulation app and slide decks to be used in grand rounds or resident training.

The NFID’s Best Practices to Increase HPV Immunization Rates contains resources to increase HPV vaccination rates and educational tools to share with patients. Resources include a Call to Action published by the NFID and links to the Association of Immunization Managers conference calls discussing increasing vaccination rates. In addition, there are links to standing orders for both adults and children and teens, articles and videos, and infographics. Finally, the NFID houses a collection of information titled Communication on HPV Vaccination. These resources include a guide to addressing parents’ questions, various fact sheets, and public service announcements.

Both organizations provide useful information to increase HPV vaccination rates in your practice. If you are working on improving HPV rates, why not take a look at CPP’s Second Dose Program where you can earn a grant for raising rates on the second dose administration of several vaccine series.

Measles Awareness Toolkit

Measles is a highly contagious infectious disease that can result in severe complications and even death. According to the Centers for Disease Control and Prevention (CDC), more than 1,200 individual cases of measles have been confirmed in 2019 in 31 states—the largest number of cases since measles was eliminated in the US in 2000.

To help combat measles and raise awareness, The National Foundation for Infectious Diseases (NFID) has compiled a wealth of information concerning Measles. They have launched a campaign to raise awareness about the risks associated with measles and the importance of prevention through vaccination. This Measles Awareness Toolkit includes short videos and infographics to share via social media.

Below are helpful resources your practice can use to educate and raise awareness about measles.

Measles Information from the NFID:

Webcast: Helping to Prevent Disease in Adults 50 Years of Age and Older

This Thursday, January 30, Sanofi Pasteur presents a webcast on influenza prevention. Join Dr. John J Russell, Clinical Professor of Family and Community Medicine at Thomas Jefferson University, and a panel of subject matter experts.

Program objectives include:

  • Examine the medical burden of influenza and its economic impact in adults 50 years of age and older
  • Explore the role that influenza can play in exacerbation of chronic conditions, leading to adverse outcomes
  • Review clinical evidence of two influenza vaccines that were compared to standard-dose influenza vaccines in older adults

There are three times to choose from: 12:15pm, 1:30pm, and 3:15pm EST.

Click here for more information.

Register here.